Literature DB >> 7901577

Anticoagulants for atrial fibrillation.

A Laupacis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7901577     DOI： 10.1016/0140-6736(93)92353-u

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Atrial fibrillation and stroke: what we know, what's new, and what we should do now.

Authors:  C S Landefeld
Journal:  CMAJ       Date:  1997-09-15       Impact factor: 8.262

2.  Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation.

Authors:  M R Antani; R J Beyth; K E Covinsky; P A Anderson; D G Miller; R D Cebul; L M Quinn; C S Landefeld
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

3.  Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?

Authors:  R J Beyth; M R Antani; K E Covinsky; D G Miller; M M Chren; L M Quinn; C S Landefeld
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

4.  Beta-adrenoceptor blockers in atrial fibrillation: the importance of partial agonist activity.

Authors:  A Herxheimer
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

Review 5.  Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice.

Authors:  K G Sweeney; D P Gray; R Steele; P Evans
Journal:  Br J Gen Pract       Date:  1995-03       Impact factor: 5.386

Review 6.  Patients with acute stroke: recent developments in neuroimaging.

Authors:  P C Combremont; M Fisher
Journal:  Curr Atheroscler Rep       Date:  2000-03       Impact factor: 5.967
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.